bluebird bio, Inc.
GENE THERAPY FOR MUCOPOLYSACCHARIDOSIS, TYPE II
Last updated:
Abstract:
The invention provides compositions and methods for treating Hunter Syndrome.
Status:
Application
Type:
Utility
Filling date:
6 Dec 2017
Issue date:
5 Mar 2020